InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Thompson Juliet, Director. Director active across 2 companies, notably Indivior Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 26 January 2026. The latest transaction was disclosed on 12 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Thompson Juliet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
1,117 股@ US$38.280.0008% mcap100.0% 占其流量Common StockSEC:0001715258-26-000007:0
3,722 股0Common StockSEC:0001715258-26-000004:0
2 条申报中的 2 条
About Thompson Juliet
Juliet Thompson is a Director at Indivior Pharmaceuticals, Inc. She contributes to the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is an asset to the board of directors. She plays a key role in the future direction of Indivior.
